GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Bought by SeaCrest Wealth Management LLC

SeaCrest Wealth Management LLC boosted its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 12.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 18,478 shares of the company’s stock after acquiring an additional 2,057 shares during the quarter. SeaCrest Wealth Management LLC’s holdings in GE HealthCare Technologies were worth $1,416,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Douglas Lane & Associates LLC boosted its position in shares of GE HealthCare Technologies by 22.1% in the 4th quarter. Douglas Lane & Associates LLC now owns 436,253 shares of the company’s stock valued at $33,731,000 after purchasing an additional 79,073 shares during the period. The Manufacturers Life Insurance Company raised its stake in shares of GE HealthCare Technologies by 34.9% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 341,769 shares of the company’s stock valued at $23,254,000 after acquiring an additional 88,384 shares in the last quarter. Federated Hermes Inc. lifted its position in GE HealthCare Technologies by 90.4% during the 3rd quarter. Federated Hermes Inc. now owns 77,689 shares of the company’s stock worth $5,286,000 after acquiring an additional 36,886 shares during the last quarter. Mackenzie Financial Corp lifted its position in shares of GE HealthCare Technologies by 61.0% during the 3rd quarter. Mackenzie Financial Corp now owns 79,989 shares of the company’s stock worth $5,358,000 after purchasing an additional 30,301 shares during the last quarter. Finally, Teacher Retirement System of Texas increased its holdings in shares of GE HealthCare Technologies by 74.0% during the 3rd quarter. Teacher Retirement System of Texas now owns 96,540 shares of the company’s stock worth $6,569,000 after purchasing an additional 41,057 shares during the period. 82.06% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on GEHC shares. Mizuho lifted their price objective on GE HealthCare Technologies from $94.00 to $96.00 and gave the company a “buy” rating in a report on Wednesday, February 7th. HSBC began coverage on shares of GE HealthCare Technologies in a report on Thursday, February 15th. They issued a “buy” rating and a $100.00 price target for the company. UBS Group upgraded shares of GE HealthCare Technologies from a “sell” rating to a “neutral” rating and increased their price objective for the company from $66.00 to $88.00 in a report on Monday, February 12th. Jefferies Financial Group started coverage on GE HealthCare Technologies in a research report on Thursday, November 30th. They set a “hold” rating and a $80.00 target price for the company. Finally, Morgan Stanley lifted their target price on GE HealthCare Technologies from $74.00 to $86.00 and gave the stock an “equal weight” rating in a report on Monday, February 12th. Five equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat.com, GE HealthCare Technologies currently has a consensus rating of “Moderate Buy” and an average target price of $88.73.

GE HealthCare Technologies Stock Up 0.7 %

GEHC traded up $0.60 on Thursday, hitting $90.91. 2,108,042 shares of the company were exchanged, compared to its average volume of 3,617,774. The stock’s fifty day moving average is $84.70 and its 200-day moving average is $75.39. GE HealthCare Technologies Inc. has a 12 month low of $62.35 and a 12 month high of $94.50. The company has a debt-to-equity ratio of 1.18, a quick ratio of 0.83 and a current ratio of 1.05. The company has a market cap of $41.40 billion, a PE ratio of 30.12, a PEG ratio of 3.10 and a beta of 0.97.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share for the quarter, beating the consensus estimate of $1.07 by $0.11. The business had revenue of $5.20 billion during the quarter, compared to analysts’ expectations of $5.09 billion. GE HealthCare Technologies had a net margin of 8.02% and a return on equity of 25.58%. The firm’s revenue was up 5.3% on a year-over-year basis. During the same period last year, the business earned $1.31 earnings per share. Equities research analysts predict that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be given a $0.03 dividend. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.13%. GE HealthCare Technologies’s payout ratio is 3.97%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.